- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
OTC drugs will have better labels
Labels for over-the-counter medicines will soon be easier to read as a result of a new FDA regulation.
Labels for over-the-counter medicines will soon be easier to read as a result of a new Food and Drug Administration regulation, announced Vice President Al Gore and the secretary of the Department of Health and Human Services Donna Shalala.
The new labels, which pharmaceutical manufacturers will have to adopt within six years, must follow a standardized format that clearly shows dosage, ingredients and warnings (see example at left).
"All medicines have benefits and side effects," said Jane Henney, M.D., the commissioner of the Food and Drug Administration. "The improved label will make it easier for patients and consumers to select the appropriate over-the-counter product, and it will help them use that product more effectively."
The new labeling standards, titled "Drug Facts," will require active ingredients to be listed at the top, followed by uses, warnings, directions and inactive ingredients. The Food and Drug Administration has also recommended that manufacturers list their phone numbers on the labels so that consumers can call if they have questions.
Reflecting an awareness of an aging population, the new labeling will also require larger type sizes and other graphic features to improve readability.
Americans can expect to see the first new labels on products within two years, according to the agency. PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
